Retro develops therapies for diseases driven by the biology of aging. We focus on cellular reprogramming and autophagy to rejuvenate cell and tissue function with the ultimate aim of adding 10 years to healthy human lifespan.
We’re building a mission-driven team of accomplished and kind individuals who embrace our startup culture of rapid iteration, transparency, and versatility.
Our autophagy program is advancing rapidly and leading the charge in translating our science into a first-in-human clinical trial, marking a major step toward delivering transformative therapies rooted in the biology of aging.
We’re hiring a new team member on the Autophagy team who will coordinate and optimize the operational infrastructure needed to advance our autophagy-enhancing compounds toward the clinic. In this highly cross-functional role, you’ll serve as a key link between Drug Discovery and Chemistry, Manufacturing, and Controls (CMC) to ensure a seamless transition from hit identification and lead optimization to preclinical candidate nomination. You’ll drive small-molecule discovery efforts by managing medicinal chemistry activities at CRO partners and aligning cross-functional timelines to keep projects moving forward efficiently. This role reports to the Head of Chemistry and Early Drug Development.
About you:
You share our sense of urgency and excitement, and thrive in fast-paced, interdisciplinary environments. You work well independently but will also enjoy being part of a highly-collaborative, multi-disciplinary team. You are excited to take on tough challenges and contribute to advancing therapies that extend healthy human lifespan!